INTRODUCTIONPsoriasis is a chronic, immune-mediated disease that varies widely in its clinical expression and affects approximately 2% of the population.1-3 Treatment options focus on relieving symptoms, reducing in ammation, induration,…

DISCUSSIONSurgical procedures are an essential piece of a dermatologist’s practice. In fact, it has been reported that dermatologists perform over 25 million minor surgical procedures annually.1,2 A major focus of…

INRODUCTIONPsoriasis is one of the common conditions seen by dermatologists. The worldwide prevalence is described at 2%. One-third of the patients have severe involvement and 5-30% are affected by psoriatic…

INTRODUCTIONThe advent of biologics has improved quality of life, clinical outcomes, and productivity among patients treated for psoriasis.1,2 Furthermore, several studies have found greater adherence to biologic treatments compared to…

INTRODUCTIONDermatologists are often frustrated by payer constraints that limit their ability to optimize patient treatment. Matters are increasingly contentious between payers and physicians in this age when biologics offer patients…

INTRODUCTIONPsoriasis, a chronic autoimmune disease manifested as inflammatory dermatosis, affects 1-3% of the United States population and 0.5-4.6% of the worldwide population.1 Plaque psoriasis, the most common form of the disease,…

INTRODUCTIONAtopic dermatitis (AD) is an inflammatory skin disease characterized by intense itching and recurrent eczematous lesions and associated with sleep disturbance, psychological symptoms, and impaired quality of life.1-8 It may…

INTRODUCTIONAtopic dermatitis (AD) is a common inflammatory disease of the skin that affects both adult and pediatric patients. While it primarily begins in childhood, AD persists into adulthood more than…

INTRODUCTIONActinic keratosis (AK) is a marker for photodamaged skin.1 Dermatologists treat AKs primarily because these lesions have the potential to progress to invasive squamous cell carcinoma (SCC). Most patients seek…